CA2900526C - Compositions and their use to treat heart failure with preserved injection fraction (hfpef) - Google Patents

Compositions and their use to treat heart failure with preserved injection fraction (hfpef) Download PDF

Info

Publication number
CA2900526C
CA2900526C CA2900526A CA2900526A CA2900526C CA 2900526 C CA2900526 C CA 2900526C CA 2900526 A CA2900526 A CA 2900526A CA 2900526 A CA2900526 A CA 2900526A CA 2900526 C CA2900526 C CA 2900526C
Authority
CA
Canada
Prior art keywords
nitrate
inorganic
heart failure
subject
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2900526A
Other languages
English (en)
French (fr)
Other versions
CA2900526A1 (en
Inventor
Julio A. Chirinos
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Original Assignee
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Pennsylvania Penn filed Critical University of Pennsylvania Penn
Publication of CA2900526A1 publication Critical patent/CA2900526A1/en
Application granted granted Critical
Publication of CA2900526C publication Critical patent/CA2900526C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
CA2900526A 2013-02-07 2014-02-07 Compositions and their use to treat heart failure with preserved injection fraction (hfpef) Active CA2900526C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361761863P 2013-02-07 2013-02-07
US61/761,863 2013-02-07
PCT/US2014/015300 WO2014124256A1 (en) 2013-02-07 2014-02-07 Methods of treating heart failure

Publications (2)

Publication Number Publication Date
CA2900526A1 CA2900526A1 (en) 2014-08-14
CA2900526C true CA2900526C (en) 2021-05-04

Family

ID=51300154

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2900526A Active CA2900526C (en) 2013-02-07 2014-02-07 Compositions and their use to treat heart failure with preserved injection fraction (hfpef)

Country Status (6)

Country Link
US (1) US20150366901A1 (enExample)
EP (1) EP2953631A4 (enExample)
JP (1) JP6441818B2 (enExample)
CN (1) CN105101977A (enExample)
CA (1) CA2900526C (enExample)
WO (1) WO2014124256A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014134585A1 (en) 2013-02-28 2014-09-04 Aires Pharmaceuticals, Inc. Inorganic nitrite to improve cardiopulmonary hemodynamics
AU2018237816A1 (en) * 2017-03-23 2019-10-31 Mission Salt, Inc. Beetroot-containing composition
CA3060985A1 (en) 2017-04-21 2018-10-25 Northeast Ohio Medical University Vasodilators for treatment of heart failure
WO2019055704A1 (en) * 2017-09-13 2019-03-21 Thermolife International, Llc ENRICHED ROOT POWDER PRODUCTS AND METHODS OF MAKING SAME
FI128489B (en) 2018-10-01 2020-06-15 Precordior Oy Equipment for generating information indicating cardiac abnormality

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5564157B2 (ja) * 2003-07-09 2014-07-30 ザ ガバメント オブ ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンテッド バイ ザ セクレタリー オブ ザ デパートメント オブ ヘルス アンド ヒューマン サービシーズ 心臓血管状態の処置のための亜硝酸塩の使用方法
JP2010519336A (ja) * 2007-02-26 2010-06-03 ルンドベルク，ヨン 亜硝酸塩及び硝酸塩及びこれらを含む組成物の新規使用
US20120214818A1 (en) * 2009-09-11 2012-08-23 The Board Of Trustees Of The University Of Illinois Methods of treating diastolic dysfunction and related conditions
US20120208762A1 (en) * 2009-10-27 2012-08-16 The Board Of Trustees Of The University Of Illinois Methods of Diagnosing Diastolic Dysfunction
GB201020811D0 (en) * 2010-12-08 2011-01-19 Solvotrin Innovations Ltd Compounds
WO2012142413A2 (en) * 2011-04-14 2012-10-18 Theravasc Inc. Nitrite compositions and uses thereof
WO2014134585A1 (en) * 2013-02-28 2014-09-04 Aires Pharmaceuticals, Inc. Inorganic nitrite to improve cardiopulmonary hemodynamics

Also Published As

Publication number Publication date
WO2014124256A1 (en) 2014-08-14
EP2953631A4 (en) 2017-03-01
CA2900526A1 (en) 2014-08-14
CN105101977A (zh) 2015-11-25
EP2953631A1 (en) 2015-12-16
JP6441818B2 (ja) 2018-12-19
US20150366901A1 (en) 2015-12-24
JP2016507570A (ja) 2016-03-10

Similar Documents

Publication Publication Date Title
Serhiyenko et al. Diabetic cardiac autonomic neuropathy
Juffermans et al. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock
DK2512236T3 (en) IMPROVED PROCEDURE FOR ADMINISTRATION OF BETA-HYDROXY-BETA-METHYL BUTYRATE (HMB)
Lee et al. Effects of chronic dietary nitrate supplementation on the hemodynamic response to dynamic exercise
AU2008346842A1 (en) Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
KR20100014853A (ko) 아질산염 및 질산염의 신규 용도 및 이를 함유하는 조성물
US20150366901A1 (en) Methods of Treating Heart Failure
Khanna et al. The management of hyperkalemia in patients with cardiovascular disease
US20160303177A1 (en) Nutritional supplement
Strugaru et al. Metformin induced lactic acidosis–particularities and course
US20050261238A1 (en) Method for increasing muscle mass and strength through administration of adenosine triphosphate
US20140141069A1 (en) Beta-guanidinopropionic acid for the treatment of hypertension
JP6258943B2 (ja) Ｈｍｂおよびａｔｐの組成物ならびに使用方法
US20050153020A1 (en) Composition comprising phosphate
US20200108090A1 (en) Composition of HMB and ATP and Methods of Use
Turpin Therapeutic role of dietary nitrates on cardiorespiratory function in cancer survivors
Dumler et al. Optimal dialysis for the end-stage renal disease patient with cardiovascular disease
Seto Acute Ketone Ester Supplementation On The Neuro-Cardiovascular Response To Stress In Humans
Woessner BEET-HF: The Effects of Dietary Inorganic Nitrate Supplementation on Aerobic Exercise Performance, Vascular Function, Cardiac Performance and Mitochondrial Respiration in Patients with Heart Failure with Reduced Ejection Fraction
Moura et al. Cardiovascular and Hemodynamic Complications in Dialysis
MD et al. What the clinician needs to know about medical nutrition therapy in critically ill patients in 2023: A narrative review
HK1217087B (zh) Hmb和atp的组合物及使用方法
Kim Acute Effects of Dietary Nitrate Supplementation in Postmenopausal Women
Osowska Citrulline in health and disease. Review on human studies
Ramick The effect of dietary nitrates on vascular function and exercise capacity in chronic kidney disease

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20190207

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 11TH ANNIV.) - STANDARD

Year of fee payment: 11

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250131

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20250131